Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtrer
Plus de filtres











Gamme d'année
1.
Leukemia ; 26(3): 451-60, 2012 Mar.
Article de Anglais | MEDLINE | ID: mdl-21869839

RÉSUMÉ

The vitamin E derivative (+)α-tocopheryl succinate (α-TOS) exerts pro-apoptotic effects in a wide range of tumors and is well tolerated by normal tissues. Previous studies point to a mitochondrial involvement in the action mechanism; however, the early steps have not been fully elucidated. In a model of acute promyelocytic leukemia (APL) derived from hCG-PML-RARα transgenic mice, we demonstrated that α-TOS is as effective as arsenic trioxide or all-trans retinoic acid, the current gold standards of therapy. We also demonstrated that α-TOS induces an early dissipation of the mitochondrial membrane potential in APL cells and studies with isolated mitochondria revealed that this action may result from the inhibition of mitochondrial respiratory chain complex I. Moreover, α-TOS promoted accumulation of reactive oxygen species hours before mitochondrial cytochrome c release and caspases activation. Therefore, an in vivo antileukemic action and a novel mitochondrial target were revealed for α-TOS, as well as mitochondrial respiratory complex I was highlighted as potential target for anticancer therapy.


Sujet(s)
Composés de l'arsenic/usage thérapeutique , Complexe I de la chaîne respiratoire/antagonistes et inhibiteurs , Leucémie aiguë promyélocytaire/traitement médicamenteux , Mitochondries/effets des médicaments et des substances chimiques , Oxydes/usage thérapeutique , Trétinoïne/usage thérapeutique , alpha-Tocophérol/pharmacologie , alpha-Tocophérol/usage thérapeutique , Animaux , Antinéoplasiques/pharmacologie , Antinéoplasiques/usage thérapeutique , Antioxydants/pharmacologie , Antioxydants/usage thérapeutique , Apoptose/effets des médicaments et des substances chimiques , Trioxyde d'arsenic , Caspases/métabolisme , Lignée cellulaire tumorale , Cytochromes c/métabolisme , Modèles animaux de maladie humaine , Complexe II de la chaîne respiratoire/antagonistes et inhibiteurs , Humains , Leucémie aiguë promyélocytaire/mortalité , Potentiel de membrane mitochondriale/effets des médicaments et des substances chimiques , Souris , Souris transgéniques , Cellules souches tumorales/effets des médicaments et des substances chimiques , Cellules souches tumorales/métabolisme , Protéines de fusion oncogènes/métabolisme , Stabilité protéique/effets des médicaments et des substances chimiques , Rats , Espèces réactives de l'oxygène/métabolisme , Transplantation isogénique
2.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;43(7): 619-626, July 2010. ilus
Article de Anglais | LILACS | ID: lil-550741

RÉSUMÉ

Micro-ribonucleic acids (microRNAs) are small molecules containing 20-23 nucleotides. Despite their small size, it is likely that almost every cellular process is regulated by them. Moreover, aberrant microRNA expression has been involved in the development of various diseases, including cancer. Although many data are available about the role of microRNAs in various lymphoproliferative disorders, their impact on the development of acute lymphoblastic leukemia of T-cell progenitors is largely unknown. In this review, we present recent information about how specific microRNAs are expressed and regulated during malignant T-lymphopoiesis and about their role during normal hematopoiesis.


Sujet(s)
Humains , Régulation de l'expression des gènes dans la leucémie/génétique , Hématopoïèse/génétique , microARN/physiologie , Leucémie-lymphome lymphoblastique à précurseurs T/génétique , ARN tumoral/génétique , Marqueurs biologiques tumoraux/génétique , microARN/génétique , Leucémie-lymphome lymphoblastique à précurseurs T/anatomopathologie
3.
Braz J Med Biol Res ; 43(7): 619-26, 2010 Jul.
Article de Anglais | MEDLINE | ID: mdl-20549139

RÉSUMÉ

Micro-ribonucleic acids (microRNAs) are small molecules containing 20-23 nucleotides. Despite their small size, it is likely that almost every cellular process is regulated by them. Moreover, aberrant microRNA expression has been involved in the development of various diseases, including cancer. Although many data are available about the role of microRNAs in various lymphoproliferative disorders, their impact on the development of acute lymphoblastic leukemia of T-cell progenitors is largely unknown. In this review, we present recent information about how specific microRNAs are expressed and regulated during malignant T-lymphopoiesis and about their role during normal hematopoiesis.


Sujet(s)
Marqueurs biologiques tumoraux/génétique , Régulation de l'expression des gènes dans la leucémie/génétique , Hématopoïèse/génétique , microARN/physiologie , Leucémie-lymphome lymphoblastique à précurseurs T/génétique , ARN tumoral/génétique , Humains , microARN/génétique , Leucémie-lymphome lymphoblastique à précurseurs T/anatomopathologie
4.
Biochim Biophys Acta ; 1798(9): 1714-23, 2010 Sep.
Article de Anglais | MEDLINE | ID: mdl-20488162

RÉSUMÉ

10-(Octyloxy) decyl-2-(trimethylammonium) ethyl phosphate (ODPC) is an alkylphospholipid that can interact with cell membranes because of its amphiphilic character. We describe here the interaction of ODPC with liposomes and its toxicity to leukemic cells with an ED-50 of 5.4, 5.6 and 2.9 microM for 72 h of treatment for inhibition of proliferation of NB4, U937 and K562 cell lines, respectively, and lack of toxicity to normal hematopoietic progenitor cells at concentrations up to 25 microM. The ED-50 for the non-malignant HEK-293 and primary human umbilical vein endothelial cells (HUVEC) was 63.4 and 60.7 microM, respectively. The critical micellar concentration (CMC) of ODPC was 200 microM. Dynamic light scattering indicated that dipalmitoylphosphatidylcholine (DPPC) liposome size was affected only above the CMC of ODPC. Differential calorimetric scanning (DCS) of liposomes indicated a critical transition temperature (T(c)) of 41.5 degrees C and an enthalpy (H) variation of 7.3 kcal mol(-1). The presence of 25 microM ODPC decreased T(c) and H to 39.3 degrees C and 4.7 kcal mol(-1), respectively. ODPC at 250 microM destabilized the liposomes (36.3 degrees C, 0.46 kcal mol(-1)). Kinetics of 5(6)-carboxyfluorescein (CF) leakage from different liposome systems indicated that the rate and extent of CF release depended on liposome composition and ODPC concentration and that above the CMC it was instantaneous. Overall, the data indicate that ODPC acts on in vitro membrane systems and leukemia cell lines at concentrations below its CMC, suggesting that it does not act as a detergent and that this effect is dependent on membrane composition.


Sujet(s)
Antinéoplasiques/pharmacologie , Membrane cellulaire/effets des médicaments et des substances chimiques , Leucémies/traitement médicamenteux , Phospholipides/pharmacologie , Apoptose/effets des médicaments et des substances chimiques , Lignée cellulaire tumorale , Perméabilité des membranes cellulaires/effets des médicaments et des substances chimiques , Survie cellulaire/effets des médicaments et des substances chimiques , Cellules souches hématopoïétiques/effets des médicaments et des substances chimiques , Humains , Leucémies/anatomopathologie , Liposomes , Micelles , Thermodynamique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE